Librela (bedinvetmab injection) is a monthly injectable monoclonal antibody, for which real-world drug experience data has ...
On Wednesday, the U.S. Food and Drug Administration approved a new pain management drug which could change the way healthcare ...
A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to ...
Dr. Ilana Etelzon Integrates CompuFlo® Epidural System into Practice Following Positive Clinical ExperienceROSELAND, N.J., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Inc. (NYSE: MLSS), a leading developer of ...
The traditional Chinese practice of qigong can effectively alleviate chronic low back pain (CLBP), according to a study ...
The U.S. Food and Drug Administration has approved a novel prescription pain medication that targets sodium channels involved ...
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...
Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...
The FDA has approved Journavx 50 mg oral tablets for the treatment of moderate to severe acute pain in adults, according to a ...
Understanding the link between weight and arthritis pain could be key to finding relief. Learn how small changes in lifestyle can make a big difference.